CTRI/2015/11/006385招募中2 期
Clinical Validation study on ŪnÄ?nÄ« Pharmacopoeial Formulationâ?? Zimad e Bars in Kalaf (Melasma)
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Female Subjects with 18 to 65 years of age
- •The patient presenting anyone or all signs mentioned below.
- •1. Ill defined light brown to grey brown macules on Forehead
- •2. Ill defined light brown to grey brown macules in RMR
- •3. Ill defined light brown to grey brown macules in LMR
- •4. Ill defined light brown to grey brown macules on Chin
排除标准
- •Patients with anyone of the following skin disease
- •Bahaq Aswad (pitryasis nigra)
- •oNamash (Naevus).
- •oBarash (lentigo)
- •oKhÄ«lÄ?n (mole)
- •oNishanate Quruh
- •oFitzpatrick skin type grade 1 & 2
- •Any systemic disorder requiring long term treatment.
- •Drug or alcohol addict
- •Subjects with oral contraceptive pills (OCPs)
- •Pregnant and lactating woman
- •Those who refuse to avoid cosmetics during study period
- •Subject Selection
- •Female subjects with 18 to 65 years of age
- •The patient presenting anyone or all signs mentioned below.
- •1. Ill defined light brown to grey brown macules on Forehead
- •2. Ill defined light brown to grey brown macules in RMR
- •3. Ill defined light brown to grey brown macules in LMR
- •4. Ill defined light brown to grey brown macules on Chin
研究者
相似试验
招募中
不适用
Clinical pharmacology study to evaluate the pharmacokinetics, safety and efficacy of multi-targetted tyrosine kinase inhibitor regorafenib in Japanese patients with advanced colorectal cancer.Colorectal CancerJPRN-UMIN000013939Showa University School of Medicine100
尚未招募
3 期
Treatment of Bronchial Asthma(difficulty in breathing) with Unani medicine Habb-e-BanafshaCTRI/2021/05/033781Central Council for Research in Unani Medicine CCRUM New Delhi
尚未招募
3 期
Treatment of Ulcers with Unani medicine Marham e EjazCTRI/2023/05/053014Central Council for Research in Unani Medicine CCRUM New Delhi
尚未招募
2 期
Treatment of Bleeding Gums with Unani Medicine Sunoon-e-Mukhrij-e-Rutubat.CTRI/2018/08/015447Central Council For Research In Unani Medicine
已完成
不适用
Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseasesCommon variable immunodeficiencyPrimary immunodeficiency diseases (PID)Haematological DisordersISRCTN05425999Octapharma AG (Switzerland)50